Shares of Herbalife Ltd (NYSE:HLF - Get Free Report) have earned a consensus rating of "Hold" from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $17.00.
HLF has been the topic of a number of recent research reports. Mizuho set a $17.00 target price on Herbalife in a research report on Monday, May 4th. Wall Street Zen lowered shares of Herbalife from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Citigroup restated a "buy" rating and set a $17.00 price objective (down from $21.00) on shares of Herbalife in a research note on Friday, August 7th. Finally, Weiss Ratings lowered shares of Herbalife from a "hold (c+)" rating to a "hold (c)" rating in a research note on Friday, July 24th.
Check Out Our Latest Stock Report on HLF
Institutional Investors Weigh In On Herbalife
Several hedge funds have recently modified their holdings of the company. AQR Capital Management LLC grew its position in shares of Herbalife by 236.8% in the first quarter. AQR Capital Management LLC now owns 133,245 shares of the company's stock valued at $1,150,000 after purchasing an additional 93,686 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Herbalife by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company's stock worth $517,000 after purchasing an additional 2,523 shares during the last quarter. Empowered Funds LLC lifted its stake in Herbalife by 12.9% in the 1st quarter. Empowered Funds LLC now owns 30,301 shares of the company's stock valued at $261,000 after buying an additional 3,474 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Herbalife by 3.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company's stock valued at $1,820,000 after buying an additional 6,747 shares in the last quarter. Finally, Envestnet Asset Management Inc. acquired a new stake in Herbalife in the 2nd quarter worth about $118,000.
Herbalife Price Performance
HLF opened at $12.38 on Friday. The firm has a market capitalization of $1.30 billion, a PE ratio of 7.98, a price-to-earnings-growth ratio of 0.40 and a beta of 0.87. The business's 50-day moving average is $12.42 and its two-hundred day moving average is $14.04. Herbalife has a 1 year low of $7.56 and a 1 year high of $20.40.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by ($0.03). Herbalife had a negative return on equity of 43.90% and a net margin of 3.16%.The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the previous year, the company posted $0.59 earnings per share. The business's revenue for the quarter was up 5.4% on a year-over-year basis. As a group, sell-side analysts expect that Herbalife will post 2.68 EPS for the current year.
About Herbalife
(
Get Free Report)
Herbalife Nutrition Ltd. NYSE: HLF operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.